Tumor-targeting oncolytic virus elicits potent immunotherapeutic vaccine responses to tumor antigens

Oncolytic viruses represent a promising therapeutic modality, but they have yet to live up to their therapeutic potential. Safety and efficacy concerns impel us to identify least toxic oncolytic agents that would generate durable and multifaceted anti-tumor immune responses to disrupt the tumors. He...

詳細記述

保存先:
書誌詳細
出版年:Oncoimmunology
主要な著者: Luo, Yong, Lin, Chaolong, Zou, Yidi, Ju, Fei, Ren, Wenfeng, Lin, Yanhua, Wang, Yale, Huang, Xiaoxuan, Liu, Huiling, Yu, Zeng, Liu, Pingguo, Tan, Guowei, Yuan, Quan, Zhang, Jun, Huang, Chenghao, Xia, Ningshao
フォーマット: Artigo
言語:Inglês
出版事項: Taylor & Francis 2020
主題:
Original Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7028326/
https://ncbi.nlm.nih.gov/pubmed/32117591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2020.1726168
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料